13G Filing: Venor Capital Management and Bioscrip Inc. (BIOS)

Page 15 of 15

Page 15 of 15 – SEC Filing

EXHIBIT A
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock, par value $.0001, of BioScrips, Inc., dated as of November 7, 2017, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Date: November 7, 2017
Venor Capital Management LP
By:
Venor Capital Management GP LLC, as general partner
Name:
/s/ Michael J. Wartell
By:
Michael J. Wartell
Title:
Managing Member
Date: November 7, 2017
Venor Capital Management GP LLC
Name:
/s/ Michael J. Wartell
By:
Michael J. Wartell
Title:
Managing Member
Date: November 7, 2017
Venor Special Situations Fund II LP
By: Venor Special Situations GP LLC, as general partner
Name:
/s/ Michael J. Wartell
By:
Michael J. Wartell
Title:
Managing Member
Date: November 7, 2017
Venor Special Situations GP LLC
Name:
/s/ Michael J. Wartell
By:
Michael J. Wartell
Title:
Managing Member
Date:  November 7, 2017
/s/ Jeffrey A. Bersh
Jeffrey A. Bersh
Date:  November 7, 2017
/s/ Michael J. Wartell
Michael J. Wartell

Follow Option Care Health Inc. (NASDAQ:OPCH)

Page 15 of 15